Health CarePharmaceuticals & Biotechnology
  • Price (ILa)7,000.00
  • Today's Change-261.00 / -3.59%
  • Shares traded4.05m
  • 1 Year change-45.48%
  • Beta1.2828
Data delayed at least 20 minutes, as of Jan 18 2018 15:24 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. Its specialty medicines business focuses on delivering a range of solutions to patients and providers through medicines, devices and services in various regions and markets around the world. Its specialty medicines business includes its core therapeutic areas of central nervous system (CNS) and respiratory medicines with a focus on asthma and chronic obstructive pulmonary disease. It also has specialty products in oncology, women's health and selected other areas.

  • Revenue in ILS (TTM)79.99bn
  • Net income in ILS-20.37bn
  • Incorporated1944
  • Employees56.96k
  • Location
    Teva Pharmaceutical Industries Ltd5 Basel St.,P.O. Box 3190PETAH TIKVA 49131IsraelISR
  • Phone+972 39267267
  • Fax+972 39234050
  • Websitehttp://www.tevapharm.com
More ▼

Institutional shareholders

4.92%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Nov 201718.75m1.85%
Norges Bank Investment Managementas of 31 Dec 201617.28m1.70%
Canada Pension Plan Investment Boardas of 31 Mar 20173.15m0.31%
Formuepleje A/S Fondsm�glerselskabas of 31 Dec 20162.51m0.25%
APG Asset Management NVas of 30 Jun 20172.03m0.20%
State of Wisconsin Investment Boardas of 31 Dec 20161.95m0.19%
Charles Schwab Investment Management, Inc.as of 04 Jan 20181.20m0.12%
Templeton Investment Counsel LLCas of 30 Sep 20171.13m0.11%
BlackRock Advisors (UK) Ltd.as of 04 Jan 20181.11m0.11%
Tekla Capital Management LLCas of 30 Sep 2017805.60k0.08%
More ▼
Data from 31 Dec 2016 - 30 Oct 2017Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.